1-1020177-C-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_198576.4(AGRN):​c.5C>A​(p.Ala2Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,334,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00093 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000059 ( 0 hom. )

Consequence

AGRN
NM_198576.4 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0910

Publications

1 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009748369).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.5C>A p.Ala2Asp missense_variant Exon 1 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.5C>A p.Ala2Asp missense_variant Exon 1 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6
AGRNENST00000620552.4 linkc.-410C>A 5_prime_UTR_variant Exon 1 of 39 5 ENSP00000484607.1 A0A087X208

Frequencies

GnomAD3 genomes
AF:
0.000922
AC:
139
AN:
150818
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00284
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00112
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00193
GnomAD2 exomes
AF:
0.000165
AC:
5
AN:
30378
AF XY:
0.000109
show subpopulations
Gnomad AFR exome
AF:
0.00450
Gnomad AMR exome
AF:
0.000566
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000592
AC:
70
AN:
1183116
Hom.:
0
Cov.:
28
AF XY:
0.0000484
AC XY:
28
AN XY:
578676
show subpopulations
African (AFR)
AF:
0.00197
AC:
46
AN:
23296
American (AMR)
AF:
0.000554
AC:
8
AN:
14448
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25060
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49140
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
27354
Middle Eastern (MID)
AF:
0.000308
AC:
1
AN:
3252
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
976048
Other (OTH)
AF:
0.000316
AC:
15
AN:
47424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000928
AC:
140
AN:
150924
Hom.:
0
Cov.:
31
AF XY:
0.000773
AC XY:
57
AN XY:
73742
show subpopulations
African (AFR)
AF:
0.00285
AC:
118
AN:
41352
American (AMR)
AF:
0.00112
AC:
17
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5112
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67480
Other (OTH)
AF:
0.00191
AC:
4
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000569
Hom.:
0
Bravo
AF:
0.00114
ExAC
AF:
0.0000746
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Congenital myasthenic syndrome 8 Uncertain:1
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 2 of the AGRN protein (p.Ala2Asp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 474165). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Benign
0.66
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.086
N
LIST_S2
Benign
0.18
T
MetaRNN
Benign
0.0097
T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.091
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.88
N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.19
MutPred
0.15
Loss of catalytic residue at A2 (P = 0.0372);
MVP
0.75
MPC
0.65
ClinPred
0.079
T
GERP RS
1.0
PromoterAI
-0.22
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
gMVP
0.40
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776698665; hg19: chr1-955557; API